Sulforaphane & Nrf2 Science

Should You Eat Broccoli Sprouts or Take a Supplement? An Honest Comparison

We publish science-backed deep dives on sulforaphane, cellular defense, and what the research actually says. Subscribe to the Guard blog to not miss the next one.

Thiago · 2026-05-09 · 11 min read

Should You Eat Broccoli Sprouts or Take a Supplement? An Honest Comparison

If you're reliably sprouting broccoli at home, you don't need a supplement. That is the honest version of the answer, and most brands in this category will not lead with it.

The catch is that most people are not reliably sprouting broccoli at home. They tried it once, the jar got moldy, the seeds were a bit pricey, and now they're standing in front of a wall of capsules wondering whether any of them will do what a fresh cup of sprouts is supposed to do. The honest comparison sits in the middle of those two facts, and it comes down to a single enzyme that most articles skip entirely.

Before we get to that enzyme, let's talk about the molecule you're actually looking for from broccoli sprouts or supplements. Sulforaphane is the most potent natural activator of the body's master cellular defense pathway, and broccoli, especially young broccoli sprouts, is by far the most concentrated dietary source. The wrinkle: broccoli doesn't contain sulforaphane directly. It contains a precursor called glucoraphanin, and the enzyme that converts glucoraphanin into sulforaphane is myrosinase.

Start with the enzyme, because every other comparison in this post depends on it.

Why Sulforaphane Needs Myrosinase

Go one layer deeper on the glucoraphanin you just met. On its own, it doesn't amount to much. It is a stable, sugar-bound storage compound that broccoli plants tuck away in their tissue. It does not activate cellular defense. It does not switch on detoxification enzymes. It sits there until something cleaves it.

That something is myrosinase, an enzyme stored in separate cellular compartments inside the plant. When you chew a sprout, you rupture the compartments and bring myrosinase into contact with glucoraphanin. The enzyme cleaves the sugar group, an unstable intermediate spontaneously rearranges, and you get sulforaphane.

This is where supplement manufacturing usually breaks down. The standard industrial process for making "broccoli extract" involves boiling water and high-temperature drying. Glucoraphanin is unusually stable and survives that heat. Myrosinase does not. So the typical capsule on the shelf delivers glucoraphanin without active myrosinase, which means your body has to do the conversion on its own.

Your gut bacteria can do this, partially. The conversion efficiency varies widely between individuals, with reported rates anywhere from 5% to 70%. Diet, antibiotics, gut microbiome composition, and individual genetics all influence how well your microbes pick up the slack. Fahey and colleagues reported in 2015 that glucoraphanin alone delivered around 10% bioavailability, with high inter- and intra-individual variability (Fahey et al., 2015). Glucoraphanin paired with active myrosinase delivered 35 to 40% bioavailability, with much less variability between people.

The fix is structural. Co-formulate glucoraphanin with a separate, dried, myrosinase-active source. Mustard seed powder is the most practical and cost-effective option. Radish seed and daikon also work. The two ingredients do not react inside a dry capsule because the enzymatic reaction needs water. They meet in your gut, where moisture allows the conversion to happen, and bioavailability rises into the same range that fresh sprouts deliver. Myrosinase is the headline driver of that conversion, but it is not the only lever. Ascorbic acid (vitamin C) acts as an enzymatic cofactor that supports the same reaction, which is why a few formulations now include it alongside the enzyme source.

With the conversion mechanism on the table, the next question is how much glucoraphanin is actually sitting in a real cup of sprouts to begin with.

How Much Sulforaphane Are You Actually Getting From Broccoli Sprouts?

Start with the seminal finding. In 1997, Jed Fahey, Yuesheng Zhang, and Paul Talalay published a paper in PNAS showing that 3-day-old sprouts of certain broccoli cultivars contain 10 to 100 times more glucoraphanin than mature broccoli plants (Fahey et al., 1997). That single result is why the entire sprouting movement exists. The input concentration is genuinely much higher in young sprouts than in the broccoli florets you buy at the grocery store.

But concentration is not dose, and the more useful question is: how much glucoraphanin actually lands in a real serving you would sit down and eat? The most thorough peer-reviewed answer comes from a 2019 review by Yagishita and colleagues in Molecules, with Fahey as a co-author (Yagishita et al., 2019). Across the studies they reviewed, fresh broccoli sprouts contained a mean of 0.38 µmol of glucoraphanin per gram of fresh weight. The range was 0.005 to 1.13 µmol/g, which is a more than 200-fold spread between the lowest and highest measurements.

6-17 mg
average glucoraphanin per 100g of fresh sprouts. Range: near-zero to roughly 50 mg, depending on cultivar, age, and conditions (Yagishita et al., 2019).

So a typical 100-gram cup of fresh sprouts contains somewhere around 6 to 17 milligrams of glucoraphanin on a good day. On a bad day, near zero. On an exceptional day, north of 40 milligrams. That variability is the problem. There is no standardized dose in a home-grown cup of broccoli sprouts. Cultivar matters enormously. Seed batch matters. Growing conditions matter. Age at harvest matters. Without a high-performance liquid chromatography rig in your kitchen, you have no way of knowing which cup you're eating.

Are Broccoli Sprouts Better Than Supplements?

The most-cited number in this debate comes from a 2011 crossover study. Clarke and colleagues published it in Pharmacological Research showing that sulforaphane bioavailability from fresh broccoli sprouts was roughly 7 times higher than from a glucoraphanin-only supplement at equivalent doses (Clarke et al., 2011). This is the study most pro-sprouts content cites. It is real, the methodology is solid, and the finding is correct for the supplements that were available in 2011.

What changed between 2011 and now is the supplement format. In 2026, Mastaloudis and colleagues published a randomized double-blind crossover trial in Scientific Reports directly testing what happens when mustard seed myrosinase is added to a glucoraphanin-rich broccoli seed extract (Mastaloudis et al., 2026). The result: bioavailability with the myrosinase co-formulation was 39.8%, versus 18.6% for the same glucoraphanin extract without myrosinase. Adding the enzyme roughly doubled total sulforaphane bioavailability. The first-eight-hour conversion rate jumped from 8.0% to 25.4%, a three-fold acceleration in how quickly the active compound shows up in circulation.

Yagishita's 2019 review provides the cleanest summary across study designs. Median bioavailability with a sulforaphane-rich beverage (sprouts territory) was around 70% urinary excretion. Median bioavailability with a glucoraphanin-plus-myrosinase supplement landed in the 20-40% range, depending on formulation (Yagishita et al., 2019; Fahey et al., 2015). Sprouts still come out ahead, but the margin is smaller than the 2011 number suggests, and newer co-formulations narrow it further.

Broccoli Sprout Supplement vs. Fresh Sprouts: Side-by-Side

Attribute Fresh sprouts Glucoraphanin-only supplement Glucoraphanin + myrosinase supplement
Bioavailability ~35-70% ~10% ~35-40%
Dose consistency Variable (200-fold range across studies) Standardized Standardized
Food safety FDA-flagged risk Low Low
Daily effort 3-5 day grow cycle One capsule One capsule

What Are the Practical Trade-Offs Most Articles Skip?

This is where the honest comparison gets uncomfortable for both sides. Sprouts are not a free win. Supplements are not a uniform category. The trade-offs that decide most readers' actual outcomes rarely make it into either pro-sprouts or pro-supplement content.

Start with food safety. Between 1996 and 2020, the FDA documented sprout-associated foodborne illness outbreaks in numbers that deserve to be acknowledged:

52 sprout-related outbreaks
From 1996 to 2020, the FDA has logged 52 sprout-related outbreaks, 2,700+ illnesses, 200+ hospitalizations, 3 deaths (FDA, 2022).

Sprouts are one of the highest-risk raw produce categories per serving consumed in federal surveillance data (FDA, 2022). The reason is structural: the warm, moist, dark germination environment that grows sprouts is functionally identical to ideal pathogen growth conditions. Contamination typically traces back to the seed itself, which is why even careful home growers are exposed to the same risk pattern as commercial operations. An earlier CDC review of seed-sprout outbreaks reached the same conclusion (CDC, 1999).

This is not a reason to never eat sprouts. People sprout safely all the time. It is a reason to take the practice seriously, source seeds from suppliers who test for pathogens, rinse on schedule, watch for mold, and accept that the risk is non-zero in a way that a tested capsule's risk is not.

Beyond food safety, the practical realities pile up fast. A standard sprouting cycle is 3 to 5 days from seed to harvest, with twice-daily rinsing, drainage management, and humidity control. Skipping a single rinse can cause rapid mold growth, which is a separate health concern on top of the bacterial one. After harvest, fresh sprouts last 5 to 7 days refrigerated. Travel, illness, busy weeks, or a single forgotten rinse breaks the chain. Most people do not maintain a 365-day-a-year sprouting practice. The data on supplement adherence versus fresh-food preparation is consistent across the lifestyle medicine literature: capsules win on consistency.

Then there is dose standardization, which is impossible to achieve at home. The Yagishita range we covered earlier (0.005 to 1.13 µmol per gram) means a home-grown cup could deliver near-zero or near-50 milligrams of glucoraphanin without you knowing which. Standardized supplements solve this problem in exchange for the bioavailability ceiling.

The supplement side has its own hard truth. Multiple analyses of the commercial sulforaphane category have documented gaps between what product labels claim and what independent testing actually finds in the capsule, with measured content frequently falling well short of the marketed dose (Houghton, 2019). This is not a one-brand problem. It is a category-wide pattern driven by the chemistry of sulforaphane itself, which degrades when exposed to heat, moisture, and other organic compounds during extraction and storage. The practical implication for anyone choosing the supplement route is that third-party testing and published certificates of analysis matter more than marketing copy on a label. Choose the supplement side of this decision and you've inherited the responsibility of figuring out which manufacturers actually deliver what their labels say.

When Should You Choose Each One?

If you reliably sprout, sprouts are excellent. Your bioavailability is at the top of the range, your practice is grounded in whole food, your costs are minimal once the equipment is paid for, and you've built a daily ritual that compounds over years. Source seeds from a sprouting-specific supplier with pathogen testing, rinse on schedule, watch for mold, and you've got the strongest version of this story.

If you don't reliably sprout, the question becomes which supplement. A glucoraphanin-only product gives you some sulforaphane, with high inter-person variability and ceiling-around-10% bioavailability. That is better than nothing, and it might be plenty for some people, but it is not the version that matches what sprouts deliver.

A glucoraphanin-plus-myrosinase co-formulated supplement from a transparent, third-party-tested manufacturer is the version that does. Bioavailability lands in the same range as fresh sprouts, dose consistency is standardized, food safety is a non-issue, and adherence is the highest of any option because all you have to do is open the bottle. Guard SRF will be an option in this category, built around the two ingredients the Mastaloudis trial actually measured, with vitamin C added as an enzymatic cofactor that supports the conversion further. Honestly, it doesn't have to be ours. What matters is that you land in this category, with a label you can verify and a manufacturer who shows their work.

The single most important thing to look for on a label is myrosinase. If the supplement contains glucoraphanin only, you've bought the inferior version and your body is doing the conversion in the dark. If it contains glucoraphanin and an active myrosinase source, you've bought the version the current evidence supports.

What This Comes Down To

If you can sprout reliably, sprout. Your body will get the most sulforaphane the food system can produce.

If you can't, look for myrosinase on the label. That single ingredient is the difference between a supplement that matches what sprouts deliver and one that might. The molecule is the same in either path. The only thing that varies is whether your body actually sees enough of it.

This post is about getting sulforaphane working inside your body, whether you sprout it or take it in a capsule. If you want the foundational science, our companion piece on what sulforaphane is and how it works covers the molecular mechanism in depth.

Sulforaphane handles the cleanup side. The other half is reducing what your body has to clean up in the first place. Our practical guide to reducing microplastic exposure covers that side.

Sources

  1. Fahey JW, Holtzclaw WD, Wehage SL, Wade KL, Stephenson KK, Talalay P. (2015). Sulforaphane Bioavailability from Glucoraphanin-Rich Broccoli: Control by Active Endogenous Myrosinase. PLOS One 10(11):e0140963. Foundational data showing active myrosinase triples sulforaphane bioavailability versus glucoraphanin alone.

  2. Mastaloudis A, Holcomb L, Fahey JW, et al. (2026). Exogenous myrosinase from mustard seed increases bioavailability of sulforaphane from a glucoraphanin-rich broccoli seed extract in a randomized clinical study. Scientific Reports. The current strongest RCT showing mustard seed myrosinase doubles bioavailability in the exact format used by modern co-formulated supplements.

  3. Clarke JD, Hsu A, Riedl K, Bella D, Schwartz SJ, Stevens JF, Ho E. (2011). Bioavailability and inter-conversion of sulforaphane and erucin in human subjects consuming broccoli sprouts or broccoli supplement in a cross-over study design. Pharmacological Research 64(5):456-463. The original "sprouts beat supplements 7x" comparison, accurate for glucoraphanin-only products.

  4. Yagishita Y, Fahey JW, Dinkova-Kostova AT, Kensler TW. (2019). Broccoli or Sulforaphane: Is It the Source or Dose That Matters? Molecules 24(19):3593. Comprehensive review with the canonical bioavailability comparison and sprout glucoraphanin content range.

  5. Houghton CA. (2019). Sulforaphane: Its 'Coming of Age' as a Clinically Relevant Nutraceutical in the Prevention and Treatment of Chronic Disease. Oxidative Medicine and Cellular Longevity 2019:2716870. Stability and commercial supplement landscape review.

  6. Fahey JW, Zhang Y, Talalay P. (1997). Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens. PNAS 94(19):10367-10372. The foundational paper showing 3-day sprouts contain 10-100x more glucoraphanin than mature broccoli.

  7. Atwell LL, Hsu A, Wong CP, et al. (2015). Absorption and chemopreventive targets of sulforaphane in humans following consumption of broccoli sprouts or a myrosinase-treated broccoli sprout extract. Molecular Nutrition & Food Research. Crossover study supporting parity between sprouts and myrosinase-treated extracts.

  8. U.S. Food and Drug Administration. Guidance for Industry: Standards for the Growing, Harvesting, Packing, and Holding of Sprouts for Human Consumption. Authoritative outbreak surveillance: 52 outbreaks, 2,700+ illnesses, 200+ hospitalizations, 3 deaths from 1996 to 2020.

  9. Centers for Disease Control and Prevention. (1999). Infections Associated with Eating Seed Sprouts: An International Concern. Emerging Infectious Diseases 5(5). Federal surveillance review confirming sprouts as a high-risk produce category.

Protect your cells. Join the Guard waitlist.

Be the first to know when SRF launches. Founding members get first access and preferred pricing.

No spam. Unsubscribe anytime.